NO20082922L - Terapeutisk middel for keratokonjunktive lidelser - Google Patents
Terapeutisk middel for keratokonjunktive lidelserInfo
- Publication number
- NO20082922L NO20082922L NO20082922A NO20082922A NO20082922L NO 20082922 L NO20082922 L NO 20082922L NO 20082922 A NO20082922 A NO 20082922A NO 20082922 A NO20082922 A NO 20082922A NO 20082922 L NO20082922 L NO 20082922L
- Authority
- NO
- Norway
- Prior art keywords
- therapeutic agent
- defect
- corneal
- eprosartan
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Det er beskrevet funnet av en ny anvendelse av eprosartan eller et salt derav. Eprosartan eller et salt derav viser en utmerket forbedrende effekt i en hornhinnelidelsesmodell, og er derfor nyttig som et terapeutisk middel for en keratokonjunktival sykdom, så som tørre øyne, hornhinnesår, keratitt, konjunktivitis, superfisiell punctat, keratopati, hornhinneepiteldefekter, konjunktivaleepiteldefekter, keratokonjunktivitis sicca, superior limbisk keratokonjunktivitis og filamentær keratitt.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005351712 | 2005-12-06 | ||
PCT/JP2006/324324 WO2007066678A1 (ja) | 2005-12-06 | 2006-12-06 | 角結膜障害治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082922L true NO20082922L (no) | 2008-06-27 |
Family
ID=38122824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082922A NO20082922L (no) | 2005-12-06 | 2008-06-25 | Terapeutisk middel for keratokonjunktive lidelser |
Country Status (8)
Country | Link |
---|---|
US (1) | US20090270474A1 (no) |
EP (1) | EP1958949A4 (no) |
KR (1) | KR20080074128A (no) |
CN (1) | CN101312962A (no) |
CA (1) | CA2631231A1 (no) |
NO (1) | NO20082922L (no) |
RU (1) | RU2423127C2 (no) |
WO (1) | WO2007066678A1 (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD4412C1 (ro) * | 2014-08-29 | 2016-11-30 | Алёна ДУРНЯ | Utilizare a acidului 4-({2-butil-5-[2-carboxi-2-(tiofen-2-ilmetil)et-1-en-1-il] -1H-imidazol-1-il}metil) benzoic pentru ameliorarea elasticităţii vasculare în profilaxia complicaţiilor de geneză hipertensivă |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
ATE198551T1 (de) * | 1993-07-15 | 2001-01-15 | Hoffmann La Roche | Pharmazeutische kombination, die einen hemmer des renin-angiotensin-systems und einen endothelin- antagonisten enthält |
JP3136352B2 (ja) * | 1996-01-22 | 2001-02-19 | 参天製薬株式会社 | 角結膜疾患治療剤 |
JPH10218792A (ja) * | 1997-02-12 | 1998-08-18 | Santen Pharmaceut Co Ltd | アンギオテンシン変換酵素阻害薬を有効成分とする涙液分泌促進および角結膜障害治療剤 |
WO2000066161A1 (fr) * | 1999-04-28 | 2000-11-09 | Takeda Chemical Industries, Ltd. | Preventifs / remedes / inhibiteurs de progression pour retinopathie simplex ou retinopathie preproliferante |
JP2001031636A (ja) * | 1999-05-18 | 2001-02-06 | Senju Pharmaceut Co Ltd | α−ケトアミド誘導体およびその医薬用途 |
JP2001058958A (ja) * | 1999-08-20 | 2001-03-06 | Senju Pharmaceut Co Ltd | 涙液分泌促進剤 |
US20030018044A1 (en) * | 2000-02-18 | 2003-01-23 | Peyman Gholam A. | Treatment of ocular disease |
FI114483B (fi) * | 2001-02-20 | 2004-10-29 | Jurilab Ltd Oy | Menetelmä kohonneen verenpaineen riskin osoittamiseksi ja sen käytöt |
-
2006
- 2006-12-06 EP EP06834079A patent/EP1958949A4/en not_active Withdrawn
- 2006-12-06 US US12/085,214 patent/US20090270474A1/en not_active Abandoned
- 2006-12-06 CN CNA2006800437587A patent/CN101312962A/zh active Pending
- 2006-12-06 CA CA002631231A patent/CA2631231A1/en not_active Abandoned
- 2006-12-06 RU RU2008127378/15A patent/RU2423127C2/ru not_active IP Right Cessation
- 2006-12-06 WO PCT/JP2006/324324 patent/WO2007066678A1/ja active Application Filing
- 2006-12-06 KR KR1020087011651A patent/KR20080074128A/ko not_active Application Discontinuation
-
2008
- 2008-06-25 NO NO20082922A patent/NO20082922L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2008127378A (ru) | 2010-01-20 |
RU2423127C2 (ru) | 2011-07-10 |
EP1958949A4 (en) | 2010-04-28 |
EP1958949A1 (en) | 2008-08-20 |
US20090270474A1 (en) | 2009-10-29 |
CA2631231A1 (en) | 2007-06-14 |
CN101312962A (zh) | 2008-11-26 |
WO2007066678A1 (ja) | 2007-06-14 |
KR20080074128A (ko) | 2008-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20076398L (no) | Preventivt eller terapeutisk middel for keratokonjunktive forstyrrelser | |
DK1679074T3 (da) | Terapeutisk middel til keratoconjunktive forstyrrelser | |
NO20082673L (no) | Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens | |
EA200601223A1 (ru) | Производные сульфонамида для лечения заболеваний | |
PE20110598A1 (es) | Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38 | |
DK1924264T3 (da) | Diaminopyrimidiner som p2x3- og p2x2/3-modulatorer | |
IS8372A (is) | 5-fenýl-4-metýl-þíasól-2-ýl-amínafleiður sem tálmar fosfatídýlínósítól 3 kínasaensíma (PI3) til að meðhöndla bólgusjúkdóma í öndunarvegi | |
NO20081550L (no) | Preventivt eller terapeutisk middel for sykdom forarsaket av minskning i lakrimalvaeske | |
PE20061366A1 (es) | Compuestos y composiciones como inhibidores de quinasa de proteina | |
NO20083562L (no) | Cannabinoidreseptormodulatorer | |
NO20076502L (no) | Pyrrolopyridiner nyttige som inhibitorer av proteinkinase | |
PE20090244A1 (es) | Inhibidores de la proteina activadora de la 5-lipoxigenasa (flap) | |
ECSP077985A (es) | Inhibidores de proteina cinasa derivados de pirrol (2,3-b) piridina | |
NO20071549L (no) | Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler | |
NO20080629L (no) | Tiazolderivater som AMPK-aktiverere | |
NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
EA200601141A1 (ru) | Сульфонамидные производные для лечения заболеваний | |
NO20076460L (no) | Nye fluorenderivater, sammensetninger inneholdende nevnte derivater og anvendelse derav | |
EA200800201A1 (ru) | Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида | |
NO20082768L (no) | Levodopa prodroge mesylat, sammensetninger og anvendelser derav | |
AR056636A1 (es) | Derivados del acido escuarico | |
EA200901514A1 (ru) | Новая сольватная и кристаллическая форма производных карбамоилциклогексана | |
EA200900337A1 (ru) | Сульфонамидные производные в качестве адренергических агонистов и мускариновых антагонистов | |
ATE553106T1 (de) | Heteroarylpyrrolopyridinone als kinaseinhibitoren | |
NO20075815L (no) | Formuleringer og metoder for behandling av amyloidose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |